期刊文献+

血浆晚期氧化蛋白产物与HDL亚类组成的关系

The Relationships Between HDL Subpopulation and Advanced Oxidation Protein Products
下载PDF
导出
摘要 目的探讨血浆晚期氧化蛋白产物(AOPPs)对血浆高密度脂蛋白(HDL)亚类组成及含量的影响。方法采用氯胺-T法和双向电泳免疫印迹检测法对346例受试者分别测定血浆AOPPs的相对含量和血浆HDL亚类的组成及含量。按AOPPs浓度均值加或减去一个标准差作为分割点,将受试者分为3组,即低AOPPs(AOPPs≤60μmol/L)组、中AOPPs(60μmol/L<AOPPs<90μmol/L)组、高AOPPs(AOPPs≥90μmol/L)组。结果与低AOPPs组相比,高AOPPs组中preβ1-HDL及HDL3a显著增多(P<0.001),而HDL2a、卵磷脂胆固醇酰基转移酶及HDL2b显著降低(P<0.001),各组胆固醇酯转运蛋白无变化。相关性分析表明AOPPs与血浆HDL亚类分布存在显著相关。结论随着血浆AOPPs水平的升高HDL颗粒有变小的趋势,AOPPs可能阻碍了HDL的成熟代谢。 Aim To study the influence of plasma advanced oxidation protein products (AOPPs) level on the contents of high density lipoprotein (HDL) subclasses. Methods Contents of AOPPs were detected by the chlora- mine-T method and the composition of HDL subclasses were measured with two-dimensional electrophoresis immunoblot in 346 subjects. According to the concentration of AOPPs, subjects were divided into three layers amount: low AOPPs (AOPPs≤60 μmol/L) group, middle AOPPs (60 μmnol/L 〈 AOPPs 〈 90 μmol/L) group, high AOPPs ( AOPPs≥90 μmol/L) group. Results Compared with the low AOPPs group, preβ1 -HDL and HDL3, were significantly increased (P 〈 0. 001 ), but lecithin-cholesterol acyhransferase (LCAT) , HDL2a and HDL2b were significantly decreased (P 〈 0. 001 ) in high AOPPs group. Cholesterol ester transfer protein (CETP) did not change in subjects. Correlation analysis showed AOPPs effect on changes in plasma HDL subclass. Conclusion With elevated plasma AOPPs concentration, the particle size of HDL shows a shift toward smaller size, AOPPs may hinder mature metabolism of HDL.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2013年第2期125-128,共4页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金项目(30800474) 湖南省科技厅项目(2010SK3037) 湖南省教育厅重点项目(11A104) 湖南省研究生创新项目(CX2010B385)
关键词 高密度脂蛋白亚类 晚期氧化蛋白产物 双向电泳-免疫印迹检测法 氯胺-T法 High Density Lipoprotein Subclasses Advanced Oxidation Protein Products Two DimensionalGelelectrophoresis-Immunodetection Chloramine-T Method
  • 相关文献

参考文献12

  • 1张慧平,孙福成,王抒.高密度脂蛋白与动脉粥样硬化和冠心病[J].中国动脉硬化杂志,2004,12(6):733-736. 被引量:22
  • 2吴新伟,傅明德,刘秉文,邓萍.人血清高密度脂蛋白亚类免疫印迹检测法[J].中国动脉硬化杂志,1999,7(3):253-255. 被引量:46
  • 3Atger V,Giral P,Simon A. High density lipoproteins subfractions as markers of early atherosclerosis[J].American Journal of Cardiology,1995,(02):127-131. 被引量:1
  • 4Witko-Sarsat V,Friedlander M,Capeillere Blandin C. Advanced oxidation protein products as a novel marker of oxidative stressin uremia[J].Kidney International,1996,(05):1304-1313. 被引量:1
  • 5Marsche G,Frank S,Hrzenjak A. Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo[J].Circulation Research,2009,(06):750-757. 被引量:1
  • 6Kaneda H,Taguchi J,Ogasawara K. Increased level of advanced oxidation protein products in patients with coronary artery disease[J].Atheroclerosis,2002,(02):221-225. 被引量:1
  • 7Descamps-Latscha B,Witko-Sarsat V,Nguyen-Khoa T. Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients[J].American Journal of Kidney Diseases,2005,(01):39-47. 被引量:1
  • 8Liu SX,Hou FF,Guo ZJ. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2006,(05):1156-1162. 被引量:1
  • 9Codoer-Franch P,Tavárez-Alonso S,Murria-Estal R. Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children[J].Nutrition Metabolism and Cardiovascular Diseases,2012,(03):237-243. 被引量:1
  • 10Lee M,Kim JQ,Kim J. Studies on the plasma lipid profiles,and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP)[J].Atheroclerosis,2001,(02):381-389. 被引量:1

二级参考文献33

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部